ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $145,718 | -35.4% | 30,358 | +1.1% | 0.00% | -50.0% |
| Q2 2023 | $225,608 | +85.9% | 30,041 | +11.9% | 0.00% | +100.0% |
| Q1 2023 | $121,362 | -61.1% | 26,850 | -3.1% | 0.00% | -66.7% |
| Q4 2022 | $312,213 | +46.6% | 27,703 | +24.5% | 0.00% | +50.0% |
| Q3 2022 | $213,000 | +9.2% | 22,254 | -7.8% | 0.00% | 0.0% |
| Q2 2022 | $195,000 | -72.4% | 24,130 | -42.2% | 0.00% | -75.0% |
| Q1 2022 | $706,000 | -29.9% | 41,764 | -10.9% | 0.01% | -27.3% |
| Q4 2021 | $1,007,000 | -72.4% | 46,872 | -5.2% | 0.01% | -68.6% |
| Q3 2021 | $3,652,000 | +26.8% | 49,448 | -6.1% | 0.04% | +40.0% |
| Q2 2021 | $2,881,000 | – | 52,682 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
| Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
| Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
| Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
| Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
| Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
| Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
| SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
| Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
| Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |